Arterys Cardio DL vs A View LCS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Arterys (now part of Tempus)
VS
by Coreline Soft

AI Verdict

Arterys Cardio DL is tailored for detailed cardiac MRI analysis, providing automated ventricle segmentations and advanced blood flow visualization to assess heart function. In contrast, A View LCS specializes in comprehensive thoracic CT analysis, focusing on lung cancer screening, emphysema quantification, and coronary artery calcification detection from low-dose CT scans. While both leverage AI in radiology and cardiology, their distinct imaging modalities and primary clinical applications cater to different diagnostic needs.

Choose Arterys Cardio DL if…

Choose Arterys Cardio DL if your primary need is rapid, accurate, and editable automated ventricle segmentations from cardiac MRI scans. This tool is ideal for cardiologists requiring advanced analysis, including 4D Flow post-processing for blood flow visualization and quantification, and quantitative Delayed Enhancement analysis to enhance diagnostic accuracy in cardiac imaging.

View Arterys Cardio DL →

Choose A View LCS if…

Choose AVIEW LCS if you require a comprehensive AI-powered platform for thoracic CT analysis, especially for lung cancer screening programs. This tool excels at automated lung nodule detection and classification, emphysema quantification, and concurrent coronary artery calcification scoring from a single low-dose CT scan, providing a holistic view of thoracic health.

View A View LCS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Arterys Cardio DL A View LCS
Deployment Cloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27] Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker). It can also be integrated into standard reading environments (PACS), RIS (Radiological Information System), or used as a standalone third-party application or web-based application.
FDA Status 1 AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Arterys Cardio DL

Arterys Cardio DL emphasizes rapid analysis, completing cardiac MRI interpretations in seconds compared to traditional methods taking 30-60 minutes, and offers editable automated contours for user refinement. Its 100% web-based, cloud-native platform further enhances accessibility and ease of use for clinicians. While A View LCS offers comprehensive reporting, Tool A's focus on speed and direct user interaction for its specialized task provides a more streamlined immediate user experience.

Clinical Value

A View LCS

Both tools are FDA-cleared and offer significant clinical value in their respective domains. However, A View LCS provides integrated detection and fully automatic analysis of three major thoracic diseasesu2014lung cancer, COPD, and cardiovascular diseaseu2014from a single low-dose CT scan. This comprehensive multi-modal assessment from one examination offers broader clinical utility and efficiency in patient risk stratification compared to Tool A's specialized cardiac MRI analysis.

Pricing & Value

Tie

Both Arterys Cardio DL and A View LCS require direct contact for pricing information, making it impossible to conduct a head-to-head comparison on cost. Without transparent pricing, evaluating their respective value propositions in terms of cost-effectiveness is not feasible.

Enterprise Readiness

A View LCS

A View LCS offers superior deployment flexibility, supporting cloud-based, hybrid, local on dedicated hardware, and locally virtualized solutions (VM, Docker). This extensive range of options allows it to integrate more readily into diverse enterprise IT environments and accommodate varying data governance and infrastructure preferences, a significant advantage over Arterys Cardio DL's purely cloud-based deployment.

Innovation

Arterys Cardio DL

Arterys Cardio DL holds the distinction of being described as the 'world's first internet platform for medical imaging' and the 'industry's first cloud-native imaging AI developer'. It was also the first to receive FDA clearance for a cloud-based product with Artificial Intelligence. This pioneering role in cloud-based AI for medical imaging demonstrates a higher degree of foundational innovation.

Support & Docs

Tie

Both companies appear to offer standard support channels and documentation. Arterys mentions 'Arterys support' and 'Resources' on its website, while Coreline Soft provides a 'Customer Service Team' and 'Overseas Business Department' contacts, with partners also referencing 'Support documentation'. Without more specific details on the quality, breadth, or responsiveness of their support services or the depth of their documentation, it is not possible to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Arterys Cardio DL A View LCS
Name Arterys Cardio DL A View LCS
Company ARTERYS Coreline Soft Co.
Primary Application Focus Cardiac MRI analysis, automated ventricle segmentations Thoracic CT analysis, lung cancer screening, emphysema quantification, coronary artery calcification detection
Key AI Feature (Cardiac) Automated ventricle segmentations for cardiac MRI Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass)
Key AI Feature (Other) 4D Flow post-processing for blood flow visualization and quantification Automated lung nodule detection and classification

Videos

Demos, reviews, and walkthroughs featuring Arterys Cardio DL and A View LCS.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Arterys Cardio DL is an AI software focused on cardiac MRI analysis, providing automated, editable ventricle segmentations. AVIEW LCS specializes in comprehensive thoracic CT analysis, including lung cancer screening, emphysema quantification, and coronary artery calcification detection from low-dose CT scans.
Arterys Cardio DL offers automated ventricle segmentations for cardiac MRI, 4D Flow post-processing for blood flow visualization and quantification, and Quantitative Delayed Enhancement analysis. AVIEW LCS provides Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass) and segmentation of major coronary arteries from CT scans.
AVIEW LCS explicitly offers automated comprehensive report generation in formats such as PDF, DICOM PDF, and SR. Arterys Cardio DL focuses on rapid analysis and editable contours for cardiac MRI but does not explicitly mention automated report generation in its description.
Arterys Cardio DL is focused solely on cardiac MRI analysis. AVIEW LCS provides significant non-cardiac capabilities, including automated lung nodule detection and classification, nodule volume quantification, Lung-RADS scoring, and emphysema analysis and quantification.
AI Tool Finder
AI-powered search. Results may not be comprehensive.